← Back
Data updated: Mar 10, 2026
JAZZ PHARMS
OncologyRespiratoryGastroenterology
JAZZ PHARMS is a specialty pharmaceutical company focused on Oncology, Respiratory, Gastroenterology. Key products include DEFITELIO.
2002
Since
5
Drugs
-
Trials
6
Approved (2yr)
Recent Activity
XYREM 2025-07-28
REMS
XYREM 2025-05-21
REMS
ZIIHERA 2024-11-20
Type 1 - New Molecular Entity
XYREM 2024-11-18
REMS
XYREM 2024-05-22
REMS
RYLAZE 2024-04-15
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 50%
2 drugs
Respiratory 25%
1 drugs
Gastroenterology 25%
1 drugs
Pipeline Strength Pro
Loading...